Skip to content
Login
Search:
CROI Conference
CROI ConferenceCROI Conference
  • About CROI
    • CROI 2027 Important Dates
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • CROI Abstract Categories
    • Abstract Guidelines and Submission
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Who Can Attend
    • Letter Of Invitation (For Visa And Other Purposes)
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
  • Program
    • CROI 2027 Program
    • Our Voices
    • Media
    • Embargo Policies And Press Release Policies
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • About CROI
    • CROI 2026 Preliminary Important Dates and Deadlines
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • Abstract Guidelines and Submission
    • CROI Abstract Categories
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Oral Abstract Presentation Guidelines
    • Poster Presentation Guidelines
    • Themed Discussion Guidelines
    • Plain Language Summaries: A Mile-High View at CROI 2026
    • People-First Language and the Use of Appropriate Terminology
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Registration
    • Who Can Attend
    • Media Accreditation and Registration
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
    • Scholarship Travel
  • Program
    • CROI 2027 Program
    • CROI 2026 Resources
    • Our Voices
    • Media
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • CROI 2027 Important Dates

Search Results for: node/PEP: Remember Me?

DORAVIRINE CONCENTRATIONS AND HIV-1 RNA SUPPRESSION IN MALE AND FEMALE GENITAL FLUIDS

By Jimmy He PharmD, DScApril 22, 2021

…baseline and week 8. Validated liquid chromatography-tandem mass spectrometry (‘LC-MS/MS) was used to quantify DOR concentrations, and HIV-1 RNA was determined by real-time PCR (Abbott). Data are presented as median…

19 – Cellular and Tissue Sources of Viral Persistence and Rebound

By Jimmy He PharmD, DScMarch 18, 2025

…like central memory (Tcm), which harbor latent provirus. Tissue-specific sources include lymphoid tissues (lymph nodes, spleen, and gut-associated lymphoid tissue), where virus can persist despite ART. The central nervous system…

Type I Interferon Signaling Is Critical for Early Control of Immune System Damage

By Enthusiast Inc MDSeptember 29, 2014

…SIV infection accelerated progression to AIDS and death. Its mechanism and the consequences of exogenous IFN-I treatment during acute infection are unknown. Methodology: 6 rhesus macaques (RMs) received IFN-1ant and…

PREDICTED SUCCESS OF PrEP USERS’ PREFERRED NONDAILY TENOFOVIR/EMTRICITABINE REGIMENS

By Jimmy He PharmD, DScApril 22, 2021

…1st dose, ~50% of RT profiles achieved ME; ~88% achieved it 24hr post-dose. No regimen achieves ME in CT; ~70% of CT profiles achieved EC90 at 24hr post-dose. ME was…

1349 – Social Networks Influence PrEP Use and Preference for Long-Acting PrEP Among MSM In Baltimore

By Jimmy He PharmD, DScMarch 20, 2025

…populations, such as men who have sex with men (MSM). Methods We conducted a network-based online survey among MSM and transgender women (TGW) in Baltimore, MD that included PrEP use…

HIGH LUNG LEVELS OF ACTIVE TRIPHOSPHATE PREDICTED WITH ORAL AT-527 IN COVID PATIENTS

By Jimmy He PharmD, DScApril 22, 2021

…the free base form, and metabolites including AT-273, the guanosine nucleoside metabolite, a surrogate for intracellular AT-9010. AT-527 was well tolerated with no discontinuations, serious AEs, clinically significant changes in…

Predictors of Viral Control After ART Interruption in SIV-Infected Rhesus Macaques

By Enthusiast Inc MDFebruary 16, 2016

…Understanding the mechanisms behind durably containing HIV replication may guide new strategies towards HIV remission. Here, we used the well-established model of SIV-infected rhesus macaques (RMs) to investigate the features…

THE LATENT SIV RESERVOIR IS ESTABLISHED INDEPENDENT OF CYTOTOXIC T LYMPHOCYTE CONTROL

By Jimmy He PharmD, DScApril 4, 2022

…However, whether these latently infected cells are formed directly after integration or following a phase of productive infection remains unclear. In this study, we addressed this question in SIV-infected rhesus…

SINGLE-CELL TRANSCRIPTOMICS TO EVALUATE HIV LATENCY ESTABLISHMENT IN CD4 T CELLS

By Enthusiast Inc MDMarch 5, 2018

…T cell function and metabolism by Fluidigm Biomark assay. Single-cell sorting of U, L, and P cells (62 cells per group) was performed using cells from one tonsil donor for…

SUPERIOR PROTECTION AGAINST SHIV INFECTION BY SAME SITE DNA-PROTEIN COIMMUNIZATION

By Jimmy He PharmD, DScApril 28, 2020

…by separate administration of the DNA and Protein components in contralateral sites. Female rhesus macaques (20 animals/group) were immunized with a 6-valent vaccine including DNA plasmids expressing membrane-anchored gp145 Env…

←1
2345678910111213141516171819202122232425262728293031323334353637383940414243444546474849505152535455565758596061626364656667
…6869707172…
73747576777879808182
83→
Copyright © 2026 CROI Foundation/IAS-USA. All Rights Reserved.
Website by Enthusiast, Inc.
  • About CROI
  • Presenters
  • Abstracts
  • Scholarships
  • Program
Footer Menu
Go to Top